Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Correlogic Systems and JEOL Sign Research and Development Agreement

Abstract:
Joint Efforts to Advance Clinical Application of Mass Spectrometry

Correlogic Systems and JEOL Sign Research and Development Agreement

ROCKVILLE, MD | Posted on June 6th, 2007

Correlogic Systems, Inc. and JEOL, Ltd. today announced the signing of a research and development
agreement focused on further enhancing the performance of mass spectrometry
in a clinical setting. JEOL, headquartered in Tokyo, is a leading global
manufacturer of scientific instruments used for research and development in
the fields of nanotechnology, life sciences, optical communication,
forensics, and biotechnology. Correlogic, based in Rockville, Maryland has
pioneered the use of pattern recognition technologies for the development
of proteomic, metabolomic, and genomic based clinical prognostic and
clinical diagnostic tests. Correlogic and JEOL have collaborated for more
than a year under an informal agreement, and have made great strides in the
continuing validation of various mass spectrometer-based assays. Details of
the agreement were not released.

Over the past year, we have had a very close and productive research
collaboration with JEOL," said Peter J. Levine, President and CEO of
Correlogic Systems, Inc. "This agreement formalizes our link to one of the
world's leading mass spectrometer and NMR manufacturers."

####

About Correlogic Systems, Inc.
Correlogic Systems, Inc. has developed patented technology and processes with a wide variety of applications for biomarker discovery, disease detection, and new drug discovery. The technology's first application has been in the field of proteomics -- the study of human proteins. OvaCheck(R), a blood test for the early detection of ovarian cancer, is Correlogic's first diagnostic test using its patented "Hidden Patterns" approach. The test is undergoing the final stages of its extensive validation process. Correlogic has entered into marketing
agreements with Quest Diagnostics, Inc., and Laboratory Corporation of America for North America. Mitsui & Co., Ltd. and Quest Diagnostics are equity investors in Correlogic. Visit Correlogic at http://www.correlogic.com .

About JEOL, Ltd. JEOL is a world leader in electron optical equipment
and instrumentation for high-end scientific and industrial research and
development. Core product groups include electron microscopes (SEMs and
TEMs), instruments for the semiconductor industry (electron beam
lithography and a series of defect review and inspection tools), and
analytical instruments including mass spectrometers, NMRs and ESRs.
Headquartered in Tokyo, Japan, the company has offices throughout the
world.

Cautionary Statement: Certain statements contained in this release are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements are based on management's
current expectations and are subject to uncertainty and changes in
circumstances. Actual results could differ materially due to, among other
things, operational and other difficulties associated with integrating
acquired business, general business conditions, competition among managed
care companies, rising health costs, trends in medical loss ratios, health
care reform, delay in receipt of regulatory and other approvals for pending
transactions and other regulatory issues.

For more information, please click here

Contacts:
Annette Fribourg
VP Government & Public Relations

301/795-1707

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Nanoparticles could allow for faster, better medicine: Exposure of nanoparticles in the body allows for more effective delivery November 20th, 2017

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

Tools

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

Nanometrics Announces $50 Million Share Repurchase Program November 15th, 2017

Nanometrics Board of Directors Names Pierre-Yves Lesaicherre President and CEO November 14th, 2017

Oxford Instruments announces winner of the 2017 Sir Martin Wood Prize for Japan November 14th, 2017

Alliances/Trade associations/Partnerships/Distributorships

EC Project Aims at Creating and Commercializing Cyber-Physical-System Solutions November 14th, 2017

GLOBALFOUNDRIES, Fudan Team to Deliver Next Generation Dual Interface Smart Card November 14th, 2017

Leti Coordinating Project to Develop Innovative Drivetrains for 3rd-generation Electric Vehicles: CEA Techís Contribution Includes Litenís Knowhow in Magnetic Materials and Simulation And Letiís Expertise in Wide-bandgap Semiconductors October 20th, 2017

More 22 of 59,885 Print all In new window Leti to Present Update of CoolCube/3DVLSI Technologies Development at 2017 IEEE S3S: Future Developments and Tape-Out Vehicles to Be Presented during Oct. 17 Workshop October 12th, 2017

Research partnerships

EC Project Aims at Creating and Commercializing Cyber-Physical-System Solutions November 14th, 2017

Leti Joins DARPA-Funded Project to Develop Implantable Device for Restoring Vision November 9th, 2017

Nanoshells could deliver more chemo with fewer side effects: In vitro study verifies method for remotely triggering release of cancer drugs November 8th, 2017

Ames Laboratory, UConn discover superconductor with bounce October 25th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project